Skip to content
EvidenceHelixEvidenceLib · Scientific Encyclopedia
⌘ K

Scientific library

EvidenceLib encyclopediaAll articles A–Z2,835
Books209
All textbooksMedical textbooksHuman anatomyOrganisms & biodiversityOther sciences
Open-access articles1,406Cancer study catalog458How it is made

My workspace this browser

Saved pages0Notes & annotations0

Recently viewed

Explore by field

Cancer and Oncology182Genetics and Genomics170Neuroscience185Cardiovascular Medicine180Immunology142Pharmacology173Molecular Biology161Infectious Diseases150Rare and Inherited Diseases181Clinical Research173Anatomy and Physiology613Drugs and Chemicals621Psychiatry and Psychology185Public Health and Nutrition178Diagnostics and Medical Technology125Respiratory Medicine113Digestive System and Liver91Metabolism and Endocrine Disease177Bones, Joints, Muscles and Skin213Kidney, Urology and Women's Health173Eye, Ear, Nose and Throat55
Plans & pricingCompare EvidenceHelix workspace plans
Library›Open textbooks›A nurse-led, preventive, psychological intervention to reduce PTSD symptom severity in critically ill patients: the POPPI feasibility study and cluster RCT›Cluster randomised clinical trial results: sites and patients

Continue where you left off ()

GO BEYOND THE PAGEReading is just the beginning.

Turn scientific reading into research. Compare studies, examine evidence, and organize your findings in EvidenceHelix Workspace.

Explore Research Workspace →

A nurse-led, preventive, psychological intervention to reduce PTSD symptom severity in critically ill patients: the POPPI feasibility study and cluster RCT · Cluster randomised clinical trial results: sites and patients

Cluster randomised clinical trial results: sites and patients

CC BY 4.0 · NIHR Journals Library · approximately 19 min read

Participants: sites

Site selection

Expressions of interest to participate in the POPPI cluster RCT were received from 118 NHS adult, general critical care units across England, Wales and Northern Ireland. Potential sites were asked to complete a site feasibility questionnaire, of which 86 completed questionnaires and were subsequently assessed for eligibility by the ICNARC CTU.

Relative to the target of 24 participating sites – of 86 potential sites completing a questionnaire – 32 sites did not meet inclusion criteria (e.g. had insufficient resources/capacity to deliver the trial or would see too few patients over the trial period). The final 24 sites were selected from the remaining 54 sites, with reasons for selection including good research track-record and display of a high level of enthusiasm. A small number of sites were already delivering early psychological support and so were not selected. In addition to the 24 sites, we selected eight reserve sites to be approached in the event that a selected site was no longer able to participate.

One site that was initially selected lost eligibility to take part as a result of inability to implement use of the CAM-ICU68 to assess delirium prior to the start of the trial (see Chapter 4 for the inclusion criteria for sites). A site from the reserve list was rapidly set up as a replacement.

Site set-up

A total of 24 sites (22 in England, one in Wales and one in Northern Ireland) obtained local NHS permissions/approvals and opened to recruitment in three groups of eight sites, at 2-month intervals. Sites allocated to the first group opened to recruitment on 1 September 2015. Groups two and three opened on 2 November 2015 and 4 January 2016, respectively. One site in group three opened 3 days late, owing to delays in obtaining local NHS permissions through the Christmas/New Year period. Site initiation visits were carried out at all participating sites prior to start of patient screening and recruitment. Sites were randomised in their second month of recruitment (during the baseline period). The flow of sites (clusters) through the cluster RCT is presented in Figure 12, according to the CONSORT extension for cluster trials.80

FIGURE 12 The CONSORT flow of sites (clusters) and patients. ICU, intensive care unit. Reproduced with permission from JAMA 2019;321(7):665–75.71 Copyright © 2019 American Medical Association. All rights reserved. (Figure not reproduced here; see the original article.)

Overall, as planned, 24 sites participated in the POPPI cluster RCT. One site from the second group of sites closed in December 2016 prior to the end of the recruitment period because key staff were scheduled onto other projects when the recruitment period was extended. The remaining 23 sites remained open to screening and recruitment until the end of recruitment in January 2017.

Intervention site set-up

Following site randomisation, each intervention group site identified three self-selected POPPI nurses (plus one reserve), according to the person specification. Each POPPI nurse signed a form confirming their commitment to undertake the POPPI nurse role. Intervention site initiation visits were carried at all intervention group sites ahead of the 3-day training course and prior to commencement of the transition period.

In total, 38 POPPI nurses were trained across the series of three central 3-day training courses held in February, April and June 2016. For two sites, the reserve POPPI nurses was also trained – one because an original POPPI nurse went on a career break and the other to help provide increased cover for delivery of the stress support sessions at one of the larger participating intervention group sites.

Characteristics of participating sites

The characteristics of the 24 adult, general critical care units that participated in the POPPI cluster RCT compared with all other adult, general critical care units in the CMP (n = 191) are presented in Table 6. Overall, a representative mix of university and non-university/university-affiliated hospitals, geographically spread across England, Wales and Northern Ireland, took part in the cluster RCT. A higher proportion of larger units participated in the POPPI cluster RCT compared with all other units participating in the CMP. Use of diaries in the critical care units was reported at the start of the study at nine intervention and seven control sites.

TABLE 6 Representativeness of participating adult, general critical care units
Critical care unit characteristicUnits in the POPPI cluster RCT (N = 24), n (%)Units in the CMPa (N = 191), n (%)
Region
North8 (33.3)55 (28.8)
Midlands/East3 (12.5)35 (18.3)
London/South East2 (8.3)50 (26.2)
South West/South Central9 (37.5)29 (15.2)
Wales1 (4.2)14 (7.3)
Northern Ireland1 (4.2)8 (4.2)
Type of hospital
University8 (33.3)56 (29.3)
Non-university/university affiliated16 (66.7)135 (70.7)
Size of critical care unit (beds)
< 82 (8.3)33 (17.3)
8–115 (20.8)68 (35.6)
12–157 (29.2)36 (18.8)
≥ 1610 (41.7)54 (28.3)
Annual critical care unit admissions
< 5002 (8.3)47 (24.6)
500–7495 (20.8)62 (32.5)
750–9998 (33.3)41 (21.5)
≥ 10009 (37.5)41 (21.5)

Participants: patients

Screening

Table 7 summarises data from screening and enrolment logs maintained by participating sites, stratified by treatment group (usual care or intervention) and time period (baseline, transition and intervention).

TABLE 7 Screening and recruitment by treatment group and time period
Screening and recruitmentBaseline periodTransition periodIntervention period
Usual careInterventionUsual careInterventionUsual careIntervention
Not eligible, n/N (% of screened)4543/5051 (89.9)3724/4257 (87.5)830/927 (89.3)728/827 (88.0)7240/8106 (89.3)6432/7290 (88.2)
Did not meet stable criteria (n)a3644313165859958285393
 < 48 hours in critical care unit, n (%)2129 (58.4)1898 (60.6)405 (61.6)391 (65.3)3351 (57.5)3461 (64.2)
 No level 3 care in first 48 hours in unit, n (%)1407 (38.6)1089 (34.8)216 (32.8)176 (29.4)2253 (38.7)1652 (30.6)
 Aged < 18 years, n (%)26 (0.7)19 (0.6)8 (1.2)0 (0)59 (1.0)30 (0.6)
 Not English-speaking, n (%)45 (1.2)27 (0.9)6 (0.9)4 (0.7)80 (1.4)27 (0.5)
 Previously recruited to the POPPI intervention, n (%)16 (0.4)16 (0.5)8 (1.2)2 (0.3)33 (0.6)24 (0.4)
 Chronic cognitive impairment,b n (%)92 (2.5)49 (1.6)18 (2.7)14 (2.3)113 (1.9)97 (1.8)
 Psychotic illness,b n (%)77 (2.1)76 (2.4)15 (2.3)15 (2.5)134 (2.3)134 (2.5)
 Chronic PTSD,b n (%)9 (0.2)2 (0.1)1 (0.2)1 (0.2)23 (0.4)23 (0.4)
Did not meet transient criteria (n)a89959317212914121039
 Not able to communicate orally, n (%)384 (42.7)118 (19.9)54 (31.4)22 (17.1)426 (30.2)214 (20.6)
 RASS score not between + 1 and –1, n (%)172 (19.1)76 (12.8)30 (17.4)11 (8.5)239 (16.9)158 (15.2)
 GCS score of < 15, n (%)543 (60.4)304 (51.3)105 (61.0)59 (45.7)814 (57.6)563 (54.2)
 Receiving end-of-life care, n (%)289 (32.1)248 (41.8)59 (34.3)48 (37.2)404 (28.6)394 (37.9)
 Not able to consent, n (%)199 (22.1)81 (13.7)34 (19.8)21 (16.3)323 (22.9)191 (18.4)
Potentially eligible (n)5085339799866858
 Missed (e.g. out-of-hours, no staff), n (%)96 (18.9)144 (27.0)17 (17.5)27 (27.3)194 (22.4)247 (28.8)
 Other reasons not approached, n (%)32 (6.3)28 (5.3)4 (4.1)3 (3.0)46 (5.3)75 (8.7)
 Approached for informed consent, n (%)380 (74.8)361 (67.7)76 (78.4)69 (69.7)626 (72.3)536 (62.5)
Eligible and approached for consent (n)3803617669626536
 Declined consent, n (%)95 (25.0)76 (21.1)18 (23.7)27 (39.1)180 (28.8)194 (36.2)
 Provided informed consent, n (%)285 (75.0)285 (78.9)58 (76.3)42 (60.8)446 (71.2)342 (63.8)
Withdrew consent, n (%)1 (0.4)2 (0.7)0 (0)0 (0)0 (0)2 (0.6)
Included in primary analysis (n)28428300446340

Of the patients who were deemed to be potentially eligible for the trial, the numbers of patients who were reported as being missed appeared to increase over time, in both usual care and intervention sites. The most commonly reported reason was that there was a relatively short time frame from a patient regaining capacity and being discharged from the critical care unit (the initial approach for consent was to be made in the unit). In addition, patients were often also missed because of a lack of resources to enable screening and recruitment in the evenings and at weekends. A similar trend was observed with regards to refusals of consent, with increasing refusals over time in both treatment groups, but higher rates of refusals being observed in patients at intervention group sites during the intervention period. The reported reasons for declining consent varied (but were consistent across treatment groups and time periods); often, patients felt too tired/fatigued to take part, others felt that they were not ‘up to’ completing questionnaires and that taking part in a research study would be burdensome to them. Some patients were already taking part in other studies and therefore did not want to consider a further study (even when co-enrolment was permitted between the studies).

Recruitment

A total of 1458 participants were recruited between 1 September 2015 and 3 February 2017. Figure 13 shows the cumulative patient recruitment against the anticipated pre-trial sample size and the revised minimum target. There was variation across the 24 participating sites in the rate of recruitment; the overall mean monthly recruitment rate was 4.1 (range 1.8–6.6) patients per site per month.

FIGURE 13 Patient recruitment. (Figure not reproduced here; see the original article.)

Patients were generally recruited into the POPPI cluster RCT during weekdays (Monday to Friday). Less than 10% of patients were recruited on either a Saturday or a Sunday (Figure 14). Most participating sites reported having insufficient resources to enable screening and recruitment outside usual office hours. Five participants (0.3%) withdrew consent, resulting in 1453 participants being included in the final sample. The 100 participants recruited during the transition (training) period were excluded from the primary analyses, as planned.

FIGURE 14 Percentage of patients recruited by day of the week. (Figure not reproduced here; see the original article.)

Patient characteristics

The groups were well matched across treatment groups and time periods (Tables 8–10). The mean age of patients was similar (baseline period: 57.2 years in the usual care group and 59.5 years in the intervention group; intervention period: 57.2 years in the usual care group and 60.4 years in the intervention group). The sample was predominantly white in ethnicity and ≈60% of recruited participants were male (this proportion was slightly lower at intervention group sites during the intervention period: 55% male).

TABLE 8 Patient characteristics: demographics
CharacteristicBaseline periodIntervention period
Usual care (N = 284)Intervention (N = 283)Usual care (N = 446)Intervention (N = 340)
Age (years)
Mean (SD)57.2 (16.2)59.5 (16.0)57.2 (15.6)60.4 (15.0)
Median (IQR)60 (46–69)62 (48–72)58 (47–68)62 (51–70)
Sex, n (%)
Female105 (37.0)115 (40.6)178 (39.9)153 (45.0)
Male179 (63.0)168 (59.4)268 (60.1)187 (55.0)
Ethnicity, n (%)
White264 (93.0)254 (89.8)406 (91.0)320 (94.1)
Mixed1 (0.4)0 (0.0)2 (0.4)1 (0.3)
Asian3 (1.1)4 (1.4)6 (1.3)1 (0.3)
Black1 (0.4)7 (2.5)2 (0.4)3 (0.9)
Other0 (0.0)8 (2.8)4 (0.9)2 (0.6)
Not stated15 (5.3)10 (3.5)26 (5.8)13 (3.8)
Quintile of IMD 2015, n (%)
1 (least deprived)57 (20.1)41 (14.5)95/445 (21.3)57/338 (16.9)
265 (22.9)46 (16.3)107/445 (24.0)74/338 (21.9)
352 (18.3)56 (19.8)73/445 (16.4)76/338 (22.5)
457 (20.1)71 (25.1)88/445 (19.8)73/338 (21.6)
5 (most deprived)53 (18.7)69 (24.4)82/445 (18.4)58/338 (17.2)
Documented pre-existing anxiety/depression, n (%)
Anxiety4 (1.4)3 (1.1)9 (2.0)12 (3.5)
Depression19 (6.7)19 (6.7)33 (7.4)32 (9.4)
Both8 (2.8)17 (6.0)13 (2.9)21 (6.2)
None253 (89.1)244 (86.2)391 (87.7)275 (80.9)
TABLE 9 Patient characteristics at critical care unit admission
CharacteristicBaseline periodIntervention period
Usual care (N = 284)Intervention (N = 283)Usual care (N = 446)Intervention (N = 340)
Elective surgical admission, n (%)
Yes24 (8.5)17 (6.0)37 (8.3)20 (5.9)
No260 (91.5)266 (94.0)409 (91.7)320 (94.1)
ICNARC Physiology Scorea
Mean (SD)21.2 (7.1)21.1 (7.0)21.4 (7.2)21.0 (7.6)
Median (IQR)21 (16–25)21 (16–26)21 (17–26)20 (16–25)
APACHE II scorea
Mean (SD)16.7 (5.8)16.9 (6.5)16.9 (6.2)17.7 (6.4)
Median (IQR)16 (13–20)16 (12–21)16 (13–21)17 (13–22)
TABLE 10 Patient characteristics at time of consent
CharacteristicBaseline periodIntervention period
Usual care (N = 284)Intervention (N = 283)Usual care (N = 446)Intervention (N = 340)
Duration of critical care unit stay prior to consent (days)
 Mean (SD)9.1 (7.4)9.8 (8.8)11.0 (11.6)12.1 (13.2)
 Median (IQR)6 (4–11)7 (4–12)7 (4–13)7 (4–14)
CAM-ICU positive (delirium) days in critical care prior to consentn = 113n = 162n = 180n = 147
 Mean (SD)2.3 (3.2)1.4 (2.2)2.8 (3.5)1.7 (3.0)
 Median (IQR)1 (0–3)1 (0–2)2 (1–3)1 (0–2)
Days from critical care unit admission to consent
 Mean (SD)9.6 (7.5)10.5 (9.1)11.9 (11.7)13.2 (13.4)
 Median (IQR)7 (4–12)7 (4–13)8 (5–14)9 (5–15)
Proportion of patients consented in critical care unit, n (%)236 (83.1)225 (79.5)337 (75.6)224 (65.9)
Last NEWS prior to consenta
 Mean (SD)3.1 (2.4)3.2 (2.2)2.8 (2.4)2.8 (2.1)
 Median (IQR)3 (1–5)3 (2–5)2 (1–4)3 (1–4)
STAI-6 at time of consentn = 284n = 282n = 445n = 340
 Mean (SD)43.6 (15.5)45.0 (16.0)42.1 (14.2)43.8 (17.1)
 Median (IQR)43 (30–53)43 (33–57)43 (33–50)43 (30–55)
HRQoL (health thermometer score) at time of consentn = 284n = 283n = 445n = 340
 Mean (SD)52.9 (23.3)52.4 (25.7)54.9 (23.3)51.0 (25.6)
 Median (IQR)50 (40–70)50 (35–70)50 (40–70)50 (30–70)

The majority of participants were medical admissions to the critical care unit, with a slightly higher proportion of planned surgical admissions at usual care group sites (than in intervention group sites). Patients’ severity of illness, assessed using the APACHE II scoring system and based on physiology variables during the first 24 hours of unit admission, was similar across treatment groups and time periods (median score of 16, and slightly higher at intervention group sites during the intervention period, with a median score of 17).

During the baseline period, patients were consented, on average, 9.6 (usual care group) and 10.5 (intervention group) days after admission to the critical care unit; compared with 11.9 and 13.2 days, respectively, during the intervention period. The proportion of patients consented in the unit, as opposed to on the wards after critical care discharge, was lower at intervention group sites during the intervention period than during all other trial time periods. At the time of consent, median STAI-6 and quality-of-life health thermometer scores were the same across treatment groups and time periods.

To assess case-mix representativeness, patients in the cluster RCT were compared with a best approximation of the POPPI eligibility criteria applied to the CMP database for both POPPI cluster RCT units and all other adult, general, critical care units participating in the CMP (non-POPPI units; Table 11). Patients who were recruited to the cluster RCT were representative of similar patients in the CMP, but were more likely to be white and not from the most deprived areas (according to quintile of IMD 2015).76

TABLE 11 Nesting of POPPI patients in CMP data
CharacteristicPOPPI cluster RCT patients (N = 1453)POPPI eligibility applied to the CMP dataa
POPPI sites (N = 8189)Non-POPPI sites (N = 50,208)
Age (years)
Mean (SD)58.0 (15.8)58.7 (17.1)59.3 (17.0)
Median (IQR)60 (48–70)61 (47–72)62 (48–73)
Sex (%)
Female41.239.641.0
Male58.860.459.0
Ethnicity (%)
White96.493.089.4
Mixed0.30.30.7
Asian1.23.04.8
Black1.11.93.3
Other1.01.81.9
Quintile of IMD 2015 (%)
1 (least deprived)18.016.214.6
221.017.817.4
319.219.919.4
421.821.522.6
5 (most deprived)20.024.626.0
Elective surgical admission (%)
Yes7.17.86.7
No92.992.293.3
ICNARC Physiology Scoreb
Mean (SD)21.2 (7.3)20.8 (7.3)20.4 (7.2)
Median (IQR)21 (16–26)20 (16–25)20 (15–25)
APACHE II scoreb
Mean (SD)17.1 (6.3)17.4 (6.6)16.7 (6.4)
Median (IQR)17 (13–21)17 (13–22)16 (12–21)
Critical care unit length of stay (days)
Mean (SD)11.3 (13.5)9.3 (12.5)9.9 (12.0)
Median (IQR)6 (3–13)5 (3–10)5 (3–11)

Patient follow-up

At 6 months, all participants were successfully followed up for mortality status. Of those surviving to 6 months, 79.3% completed the follow-up questionnaire (range 78.4–79.9% across treatment groups and time periods; Table 12). There were no differences in response rates between groups or time periods. The majority of questionnaires were completed on paper and returned via post.

TABLE 12 Patient follow-up by treatment group and time period
Follow-upBaseline periodIntervention period
Usual care (N = 284)Intervention (N = 283)Usual care (N = 446)Intervention (N = 340)
Outcome at 6 months, n (%)
Alive259 (91.2)245 (86.6)415 (93.0)314 (92.4)
Dead25 (8.8)38 (13.4)31 (7.0)26 (7.6)
Lost to follow-up0 (0.0)0 (0.0)0 (0.0)0 (0.0)
Returned questionnaire, n/N (% of those alive at 6 months)
Completed203/259 (78.4)193/245 (78.8)331/415 (79.8)251/314 (79.9)
Refused22/259 (8.5)25/245 (10.2)31/415 (7.5)19/314 (6.1)
Lost to follow-up34/259 (13.1)27/245 (11.0)53/415 (12.8)44/314 (14.0)
Method of completion, n/N (% of completed questionnaires)
Paper178/203 (87.7)173/193 (89.6)315/331 (95.2)240/251 (95.6)
Telephone25/203 (12.3)20/193 (10.4)16/331 (4.8)11/251 (4.4)
Method of refusal, n/N (% of those who refused)
Paper13/22 (59.1)8/25 (32.0)15/31 (48.4)10/19 (52.6)
Telephone10/22 (45.5)17/25 (68.0)16/31 (51.6)9/19 (47.4)
Complete responses by instrument, n/N (% of completed questionnaires)
PSS-SR201/203 (99.0)191/193 (99.0)330/331 (99.7)250/251 (99.6)
HADS anxiety196/203 (96.6)186/193 (96.4)327/331 (98.8)246/251 (98.0)
HADS depression196/203 (96.6)186/193 (96.4)327/331 (98.8)247/251 (98.4)
EQ-5D-5L197/203 (97.0)188/193 (97.4)320/331 (96.7)248/251 (98.8)
Health services135/203 (66.5)122/193 (63.2)226/331 (68.3)161/251 (64.1)

Of returned completed questionnaires, data completeness for the primary outcome measure (PSS-SR score) was high (> 99%). Data completeness for the HADS67 and EQ-5D-5L56 were also high (> 96%), but less complete responses were received for the health services questionnaire (note that this questionnaire appeared last in the questionnaire booklet).

For participants alive at 6 months, response rates varied by patient characteristics (Table 13). Response rates were lowest in the youngest age group, and were generally lower for females than for males, for non-white ethnicities than for those of white ethnicity, and for patients with higher levels of deprivation. However, there appeared to be no clear relationship between response rate and either baseline acute severity of illness or anxiety and HRQoL at the time of consent. For patients receiving the intervention, the response rate increased with the number of stress support sessions received.

TABLE 13 Response rate by patient characteristics
CharacteristicBaseline periodIntervention period
Usual care (N = 259), n/N (%)Intervention (N = 245), n/N (%)Usual care (N = 415), n/N (%)Intervention (N = 314), n/N (%)
Age (years)
18–4953/81 (65.4)50/68 (73.5)89/123 (72.4)47/68 (69.1)
50–5942/51 (82.4)41/50 (82.0)84/103 (81.6)61/73 (83.6)
60–6963/69 (91.3)57/67 (85.1)83/102 (81.4)77/91 (84.6)
≥ 7045/58 (77.6)45/60 (75.0)75/87 (86.2)66/82 (80.5)
Sex
Female67/94 (71.3)77/104 (74.0)129/164 (78.7)113/145 (77.9)
Male136/165 (82.4)116/141 (82.3)202/251 (80.5)138/169 (81.7)
Ethnicity
White190/240 (79.2)177/223 (79.4)298/377 (79.0)239/294 (81.3)
Non-white3/5 (60.0)9/14 (64.3)9/13 (69.2)2/7 (28.6)
Not stated10/14 (71.4)7/8 (87.5)24/25 (96.0)10/13 (76.9)
Quintile of IMD 2015
1 (least deprived)50/54 (92.6)27/31 (87.1)79/89 (88.8)46/55 (83.6)
245/55 (81.8)28/40 (70.0)84/97 (86.6)55/67 (82.1)
332/48 (66.7)43/51 (84.3)52/70 (74.3)56/66 (84.8)
440/51 (78.4)47/64 (73.4)63/83 (75.9)56/71 (78.9)
5 (most deprived)36/51 (70.6)48/59 (81.4)52/75 (69.3)36/53 (67.9)
Pre-existing anxiety/depression
Anxiety3/4 (75.0)0/1 (0.0)6/9 (66.7)9/11 (81.8)
Depression13/19 (68.4)13/18 (72.2)25/32 (78.1)24/31 (77.4)
Both4/8 (50.0)13/17 (76.5)9/11 (81.8)13/21 (61.9)
None183/228 (80.3)167/209 (79.9)291/363 (80.2)205/251 (81.7)
Elective surgical admission
Yes16/19 (84.2)9/11 (81.8)29/36 (80.6)18/19 (94.7)
No187/240 (77.9)184/234 (78.6)302/379 (79.7)233/295 (79.0)
ICNARC Physiology Score
< 1759/73 (80.8)55/75 (73.3)83/105 (79.0)73/95 (76.8)
17–2156/75 (74.7)48/64 (75.0)89/118 (75.4)82/91 (90.1)
22–2644/55 (80.0)50/61 (82.0)82/103 (79.6)48/64 (75.0)
≥ 2744/56 (78.6)40/45 (88.9)77/89 (86.5)48/64 (75.0)
APACHE II score
< 1465/80 (81.3)58/79 (73.4)90/124 (72.6)65/89 (73.0)
14–1758/79 (73.4)58/71 (81.7)100/117 (85.5)72/89 (80.9)
18–2142/50 (84.0)37/45 (82.2)74/90 (82.2)52/61 (85.2)
≥ 2238/50 (76.0)40/50 (80.0)65/82 (79.3)62/75 (82.7)
CAM-ICU positive (delirious) in unit prior to consent (days)
019/33 (57.6)50/67 (74.6)20/29 (69.0)46/61 (75.4)
1–233/41 (80.5)43/55 (78.2)65/84 (77.4)35/42 (83.3)
> 221/30 (70.0)17/22 (77.3)42/55 (76.4)30/35 (85.7)
Last NEWS prior to consent
0–156/77 (72.7)48/56 (85.7)124/157 (79.0)76/92 (82.6)
2–367/81 (82.7)70/97 (72.2)109/130 (83.8)88/116 (75.9)
426/35 (74.3)19/28 (67.9)25/37 (67.6)35/41 (85.4)
≥ 554/66 (81.8)56/64 (87.5)73/91 (80.2)52/65 (80.0)
STAI-6 score at time of consent
20–3054/71 (76.1)44/53 (83.0)81/103 (78.6)74/98 (75.5)
31–4358/70 (82.9)59/78 (75.6)111/145 (76.6)67/73 (91.8)
44–5344/58 (75.9)43/52 (82.7)78/96 (81.3)50/64 (78.1)
54–8047/60 (78.3)47/61 (77.0)60/70 (85.7)60/79 (75.9)
HRQoL health thermometer score at time of consent
0–3849/62 (79.0)48/63 (76.2)71/86 (82.6)77/92 (83.7)
39–5066/82 (80.5)54/66 (81.8)97/125 (77.6)61/82 (74.4)
51–7041/53 (77.4)46/58 (79.3)80/102 (78.4)58/72 (80.6)
71–10047/62 (75.8)45/58 (77.6)83/101 (82.2)55/68 (80.9)
IPAT score of < 7 –––103/128 (80.5)
IPAT score of ≥ 7 by number of stress support sessions received
None–––9/16 (56.3)
1–––13/19 (68.4)
2–––24/31 (77.4)
3–––102/120 (85.0)

Multiple imputation

Table 14 reports all of the variables considered for multiple imputation, and for each variable, the number of missing values, and the imputation model chosen.

TABLE 14 Variables considered for multiple imputation and form of imputation model
VariableMissing values, n (%)Imputation model
Site-level covariates
Teaching status of hospital0 (0)None required
Number of beds in the critical care unit0 (0)None required
Number of critical care unit admissions receiving level 3 care staying ≥ 48 hours0 (0)None required
Allocated treatment group0 (0)None required
Patient-level covariates
Time period0 (0)None required
Age0 (0)None required
Sex0 (0)None required
Ethnicity0 (0)None required (‘not stated’ retained as separate category)
IMD 2015 quintile3 (< 0.1)Singly imputed to category 3 (middle quintile)
Pre-existing anxiety/depression0 (0)None required
Elective surgical admission0 (0)None required
ICNARC physiology score0 (0)None required
NEWS0 (0)None required
HRQoL health thermometer score1 (< 0.1)Singly imputed to mean
STAI-6 score2 (< 0.1)Missing items singly imputed to mode
Duration of stay in the critical care unit (days)0 (0)None required
Number of days of delirium0 (0)None required (not assessed retained as separate category)
Number of days receiving sedatives/anxiolytics/anaesthetics0 (0)None required
Number of days receiving sleep medications0 (0)None required
Receipt of benzodiazepines0 (0)None required
Number of days receiving antipsychotics0 (0)None required
Number of days receiving vasoactive agents0 (0)None required
Number of days receiving analgesics0 (0)None required
Number of days receiving antidepressants0 (0)None required
Number of days receiving mechanical ventilation0 (0)None required
Duration of stay in hospital following discharge from the critical care unit (days)0 (0)None required
Adherence to intervention0 (0)None required
Length of stay in general medical wards (days)0 (0)None required
Outcomes and resource use at 6 months
Costs of ICU stay (£)0 (0)None required
Mortality0 (0)None required
PSS-SR score283 (21.4)Predictive mean matching
HADS anxiety score303 (22.9)Predictive mean matching
HADS depression score302 (22.8)Predictive mean matching
EQ-5D-5L health utility302 (22.8)Predictive mean matching
Health services questionnaire costs (£)631 (47.7)Predictive mean matching
← Cluster randomised clinical trial methodsCluster randomised clinical trial process evaluation: methods and results →

Attribution. Paul R Mouncey; Dorothy Wade; Alvin Richards-Belle; Zia Sadique; Jerome Wulff; Richard Grieve et al. (2019). A nurse-led, preventive, psychological intervention to reduce PTSD symptom severity in critically ill patients: the POPPI feasibility study and cluster RCT. NIHR Journals Library. Copyright © Queen’s Printer and Controller of HMSO 2019. This work was produced by Mouncey et al. under the terms of a commissioning contract issued by the Secretary of State for Health and Social Care. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton SO16 7NS, UK. Licensed under CC BY 4.0. NCBI Bookshelf NBK545679. CC BY 4.0. Original source ↗. Text reproduced from the Bookshelf XML without changing wording; figures, images and supplements are not reproduced.

In this chapter Contents

  • Cluster randomised clinical trial results: sites and patients

Source

OpenStax source file ↗

Source record ↗

EvidenceLib is a research-education resource, not medical advice. It does not diagnose, prescribe or recommend starting, stopping or changing any treatment. Talk to a qualified clinician about your own situation. Methods, sources and licences · Rights and removal requests · Legal · Support